Semaglutide Manufacturers: Who Actually Makes It?

Semaglutide is manufactured by Novo Nordisk, the Danish pharmaceutical company behind every FDA-approved version of the drug sold in the United States: Ozempic, Wegovy, and Rybelsus. No FDA-approved generic semaglutide exists in the U.S., although compounded versions from licensed pharmacies filled supply gaps during the 2022–2025 shortage. Understanding who makes which product matters, because approval status, quality oversight, and legal supply differ sharply between brand-name, compounded, and research-grade semaglutide.

Who Makes Semaglutide? Novo Nordisk Is the Only FDA-Approved Source

Novo Nordisk developed the semaglutide molecule and is the only company that manufactures FDA-approved semaglutide for the U.S. market. The company produces the active ingredient at large-scale fermentation facilities and fills it into injection pens and oral tablets at specialized plants.

U.S. patents covering semaglutide run into the early 2030s, so brand-name products remain the only approved supply for patients. That is why searches for semaglutide companies generally lead back to a single manufacturer, not a competitive field of FDA-approved makers.

Brand Names of Semaglutide: Ozempic, Wegovy, and Rybelsus

People often search for the brand name of semaglutide because one molecule sells under several trade names. All three approved products come from Novo Nordisk, but each is authorized for different uses.

Brand name	Manufacturer	Form	Approved use in the U.S.
Ozempic	Novo Nordisk	Once-weekly injection	Type 2 diabetes; cardiovascular and kidney risk reduction in certain patients
Wegovy	Novo Nordisk	Once-weekly injection	Chronic weight management
Rybelsus	Novo Nordisk	Once-daily oral tablet	Type 2 diabetes
Generic semaglutide	None FDA-approved	—	Not available in the U.S.

The active ingredient in Ozempic, Wegovy, and Rybelsus is chemically the same drug, which answers the common question of whether semaglutide is the same as Ozempic. The differences are dose, delivery method, and approved indication, not the molecule itself.

Where Does Semaglutide Come From?

Semaglutide is not extracted from plants or animals. It is a synthetic analog of human GLP-1, produced through recombinant DNA technology in yeast cells and then chemically modified.

An amino acid substitution and a fatty-acid side chain allow the peptide to resist rapid breakdown, which is why one injection lasts about a week. Novo Nordisk runs this process in large fermentation and fill-finish facilities, and capacity constraints there have contributed to periodic supply pressure.

In late 2024, Novo Holdings acquired contract manufacturer Catalent, and Novo Nordisk took over three fill-finish sites to expand production capacity. Manufacturing scale is a major reason brand-name semaglutide availability fluctuates.

Does Eli Lilly Make Semaglutide?

No. Eli Lilly does not manufacture semaglutide, and searches for “lilly semaglutide” usually reflect confusion with tirzepatide, which Lilly markets as Mounjaro and Zepbound.

Tirzepatide is a different molecule that activates both GLP-1 and GIP receptors, while semaglutide targets GLP-1 only. If you are choosing between them, semaglutide vs tirzepatide comes down to molecule, manufacturer, trial results, dosing schedule, and cost — not to one company producing both.

Compounded Semaglutide: Who Makes It and What Changed

During the shortage, licensed U.S. compounding pharmacies produced their own semaglutide from bulk active ingredient. Those products were never FDA-approved, and after the FDA resolved the shortage in 2025, large-scale compounding was sharply restricted.

Compounded formulations sometimes include added ingredients such as vitamin B12 or L-carnitine, which is why semaglutide l carnitine shows up in search results. Adding another ingredient does not make a compounded product FDA-approved or interchangeable with Ozempic or Wegovy.

Availability now depends on state rules, pharmacy licensing, and ongoing litigation. Patients should verify the source of any compounded product and review it with a healthcare professional.

Research-grade products sold online

Some vendors sell peptide labeled strictly for laboratory research, often with a “not for human consumption” disclaimer. These products are unregulated and unapproved. Searches such as aod 9604 and semaglutide or stacking retatrutide and semaglutide typically surface research-chemical sellers rather than pharmacies or legitimate drugmakers.

How to Identify Which Manufacturer Produced Your Semaglutide

Check the carton and pen or tablet label for the manufacturer name and a National Drug Code. FDA-approved Ozempic, Wegovy, and Rybelsus list Novo Nordisk and carry an NDC.

• Brand-name pens and tablets: manufactured by Novo Nordisk, FDA-approved, prescription only.
• Compounded vials: made by a licensed compounding pharmacy; no NDC and no FDA approval.
• Research vials: often labeled “not for human consumption,” with no licensed manufacturer listed.

Novo Nordisk also publishes guidance on spotting counterfeit or illegally imported product, since copies have appeared in some markets and through online sellers.

Manufacturer and Source Comparison

Source	Who makes it	FDA-approved	Typical status
Ozempic, Wegovy, Rybelsus	Novo Nordisk	Yes	Prescription; approved for specific uses
Compounded semaglutide	Licensed U.S. compounding pharmacies	No	Prescription, heavily restricted since 2025
Research-grade peptide	Unregulated online suppliers	No	Not for human use

Safety and Regulatory Takeaways

• Every FDA-approved semaglutide product sold in the United States is made by Novo Nordisk.
• Compounded semaglutide is not FDA-approved, even when a licensed pharmacy produces it.
• Semaglutide is a prescription medicine with real risks, including gastrointestinal effects and, in some patients, more serious complications.

Talk with a healthcare professional about semaglutide side effects, interactions, and whether the drug fits your health history before starting any version of it. Novo Nordisk is also studying new combinations in its pipeline, including cagrilintide and semaglutide, which could reshape the manufacturing picture in the years ahead.

COMMON QUESTIONS

Frequently Asked Questions

Who manufactures semaglutide?

Novo Nordisk is the only company that manufactures FDA-approved semaglutide sold in the United States. It sells the drug as Ozempic, Wegovy, and Rybelsus, and no FDA-approved generic version exists in the U.S. Compounded semaglutide is made by licensed compounding pharmacies but is not FDA-approved.

Does Eli Lilly make semaglutide?

No. Eli Lilly does not make semaglutide; it manufactures tirzepatide, sold as Mounjaro and Zepbound. Tirzepatide is a different molecule that targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1. Novo Nordisk is the sole maker of approved semaglutide products.

Is compounded semaglutide the same as Ozempic?

Compounded semaglutide contains the same active ingredient but is not FDA-approved, and it may use different salt forms such as semaglutide sodium or acetate. Its strength, purity, and dosing are not verified by the FDA the way brand-name products are. After the FDA resolved the semaglutide shortage in 2025, large-scale compounding became heavily restricted.